(Q38034733)

English

Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research

scientific article published on 14 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research (English)

1 reference

Europe PubMed Central

27 August 2017

allosteric inhibitor

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Abdelhakim Ahmed-Belkacem

3

object named as

Abdelhakim Ahmed-Belkacem

0 references

Jean-Michel Pawlotsky

4

object named as

Jean-Michel Pawlotsky

0 references

Ahcène Boumendjel

5

object named as

Ahcène Boumendjel

1 reference

Europe PubMed Central

27 August 2017

Marine Peuchmaur

2

object named as

Marine Peuchmaur

1 reference

Europe PubMed Central

27 August 2017

Romain Haudecoeur

1

object named as

Romain Haudecoeur

1 reference

Europe PubMed Central

27 August 2017

author name string

Abdelhakim Ahmed-Belkacem

3

1 reference

Europe PubMed Central

27 August 2017

Jean-Michel Pawlotsky

4

1 reference

Europe PubMed Central

27 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 August 2012

1 reference

Europe PubMed Central

27 August 2017

Medicinal Research Reviews

1 reference

Europe PubMed Central

27 August 2017

33

1 reference

Europe PubMed Central

27 August 2017

5

1 reference

Europe PubMed Central

27 August 2017

934-984

1 reference

Europe PubMed Central

27 August 2017

Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Selection and Characterization of Replicon Variants Dually Resistant to Thumb- and Palm-Binding Nonnucleoside Polymerase Inhibitors of the Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinediones

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Des-A-ring benzothiadiazines: inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Activity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee Model

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazines

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moiety

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activity

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Inhibitors of HCV NS5B polymerase. Part 2: Evaluation of the northern region of (2Z)-2-benzoylamino-3-(4-phenoxy-phenyl)-acrylic acid

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identification of anthranilic acid derivatives as a novel class of allosteric inhibitors of hepatitis C NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

1,5-Benzodiazepine inhibitors of HCV NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Inhibitors of hepatitis C virus polymerase: synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

SAR studies on a series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides: potent inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B Polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Further studies on hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors toward improved replicon cell activities: benzimidazole and structurally related compounds bearing the 2-morpholinophenyl moiety

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of benzimidazole-diamide finger loop (Thumb Pocket I) allosteric inhibitors of HCV NS5B polymerase: Implementing parallel synthesis for rapid linker optimization

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Benzimidazole Thumb Pocket I finger-loop inhibitors of HCV NS5B polymerase: improved drug-like properties through C-2 SAR in three sub-series

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Development and preliminary optimization of indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

N-Acetamideindolecarboxylic acid allosteric 'finger-loop' inhibitors of the hepatitis C virus NS5B polymerase: discovery and initial optimization studies

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Indole 5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase with nanomolar potency in cell-based subgenomic replicons (part 2): central amino acid linker and right-hand-side SAR studies

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Optimization of thienopyrrole-based finger-loop inhibitors of the hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of 4H-pyrazolo[1,5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Structure-activity relationship (SAR) studies of quinoxalines as novel HCV NS5B RNA-dependent RNA polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

The synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid hepatitis C virus polymerase NS5B inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Cyclic amide bioisosterism: strategic application to the design and synthesis of HCV NS5B polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Design and synthesis of 2,3,4,9-tetrahydro-1H-carbazole and 1,2,3,4-tetrahydro-cyclopenta[b]indole derivatives as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

The discovery of pyrano[3,4-b]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activity

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyrones

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase. Crystal structures and mechanism of inhibition

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Quinolones as HCV NS5B polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase

1 reference

https://api.crossref.org/works/10.1002%2FMED.21271

21 January 2018

Identifiers

10.1002/MED.21271

1 reference

Europe PubMed Central

27 August 2017

release_fbxte2fhcraedngkfp4y77pk5m

1 reference

https://api.fatcat.wiki/v0/release/fbxte2fhcraedngkfp4y77pk5m

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38034733&oldid=2114493219"